ABT
NYSEABBOTT LABORATORIES
Health Care, Health Care Equipment
$107.81
close 7 Aug 2026
-17.93%
52-week change
$187.78B
market cap
$81.97
$137.49
52-week range
| Line item | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||||||||||
| Revenue | $45.13B | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B | $34.61B | $31.90B | $30.58B | $27.39B | $20.85B | $20.41B | $20.25B | $19.66B | $19.05B | $21.41B | $35.17B | $30.76B | $29.53B | $25.91B |
| Cost of revenue | $19.74B | $19.32B | $18.71B | $17.98B | $19.14B | $18.54B | $15.00B | $13.23B | $12.71B | $12.41B | $9.09B | $8.75B | $9.22B | $9.19B | $8.90B | $10.02B | $14.67B | $13.21B | $12.61B | $11.42B |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $2.99B | $2.94B | $2.84B | $2.74B | $2.89B | $2.74B | $2.42B | $2.44B | $2.30B | $2.26B | $1.45B | $1.41B | $1.35B | $1.37B | $1.46B | $1.51B | $3.72B | $2.74B | $2.69B | $2.51B |
| SG&A | $13.01B | $12.33B | $11.70B | $10.95B | $11.25B | $11.32B | $9.70B | $9.77B | $9.74B | $9.18B | $6.74B | $6.79B | $6.53B | $6.37B | $6.74B | $7.37B | $10.38B | $8.41B | $8.44B | $7.41B |
| Operating income | $7.71B | $8.05B | $6.83B | $6.48B | $8.36B | $8.43B | $5.36B | $4.53B | $3.65B | $1.56B | $3.03B | $2.87B | $2.60B | $2.13B | $1.36B | $1.63B | $6.09B | $6.24B | $5.69B | $4.58B |
| Interest expense | $536.00M | $493.00M | $559.00M | $637.00M | $558.00M | $533.00M | $546.00M | $670.00M | $826.00M | $904.00M | $431.00M | $163.00M | $150.00M | $145.00M | $320.00M | $359.00M | $553.14M | $519.66M | $528.47M | $593.14M |
| Tax expense | $1.86B | $1.94B | -$6.39B | $941.00M | $1.37B | $1.14B | $497.00M | $390.00M | $539.00M | $1.88B | $350.00M | $577.00M | $797.00M | $53.00M | -$457.00M | $110.00M | $1.09B | $1.45B | $1.12B | $863.33M |
| Net income | $6.28B | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B | $4.50B | $3.69B | $2.37B | $477.00M | $1.40B | $4.42B | $2.28B | $2.58B | $5.96B | $4.73B | $4.63B | $5.75B | $4.88B | $3.61B |
| Diluted EPS | $3.57 | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 | $2.50 | $2.06 | $1.33 | $0.2700 | $0.9400 | $2.92 | $1.49 | $1.62 | $3.72 | $3.01 | $2.96 | $3.69 | $3.12 | $2.31 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | 17.07% | 18.17% | 16.27% | 16.15% | 19.16% | 19.56% | 15.48% | 14.21% | 11.94% | 5.71% | 14.51% | 14.05% | 12.84% | 10.85% | 7.14% | 7.61% | 17.31% | 20.27% | 19.28% | 17.67% |
| Net margin | 13.91% | 14.72% | 31.95% | 14.27% | 15.88% | 16.42% | 12.99% | 11.56% | 7.74% | 1.74% | 6.71% | 21.68% | 11.28% | 13.10% | 31.30% | 22.09% | 13.15% | 18.68% | 16.53% | 13.92% |
filed 29 Apr 2026